MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products for the critical care market, today announced that John Kelley, Chief Executive Officer, will present a company overview at the Leerink Partners 5th Annual Global Healthcare Conference in New York City on Thursday, February 11, 2016 at 2:40 p.m. ET.
